Phase II study of pre-operative radiotherapy with capecitabine and oxaliplatin for rectal cancer and carcinoembryonic antigen as a predictor of pathological tumour response.
about
TNF rs1799964 as a Predictive Factor of Acute Toxicities in Chinese Rectal Cancer Patients Treated With Chemoradiotherapy.Clinical factors of post-chemoradiotherapy as valuable indicators for pathological complete response in locally advanced rectal cancerCarcinoembryonic antigen expression level as a predictive factor for response to 5-fluorouracil in colorectal cancer.Addition of oxaliplatin to capecitabine-based preoperative chemoradiotherapy for locally advanced rectal cancer: Long-term outcome of a phase II study.Genetic variations in the PI3K/PTEN/AKT/mTOR pathway predict tumor response and disease-free survival in locally advanced rectal cancer patients receiving preoperative chemoradiotherapy and radical surgery.
P2860
Phase II study of pre-operative radiotherapy with capecitabine and oxaliplatin for rectal cancer and carcinoembryonic antigen as a predictor of pathological tumour response.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Phase II study of pre-operativ ...... pathological tumour response.
@en
Phase II study of pre-operativ ...... pathological tumour response.
@nl
type
label
Phase II study of pre-operativ ...... pathological tumour response.
@en
Phase II study of pre-operativ ...... pathological tumour response.
@nl
prefLabel
Phase II study of pre-operativ ...... pathological tumour response.
@en
Phase II study of pre-operativ ...... pathological tumour response.
@nl
P2093
P2860
P1476
Phase II study of pre-operativ ...... pathological tumour response.
@en
P2093
P2860
P304
P356
10.1177/147323001003800227
P577
2010-03-01T00:00:00Z